Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Anti-cancer activity of verteporfin in cholangiocarcinoma

ABSTRACT: Anti-cancer activity of verteporfin in cholangiocarcinoma

PROVIDER: PRJNA956462 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR24187849.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Anti-cancer activity of verteporfin in cholangiocarcinoma

Project description:We investigated the antitumoral effect of verteporfin in YAP/AKT hydrodynamic tail vein injected murine models and we analyzed the correlative change of immune cell profile and stemness with the treatment of verteporfin by using flow cytometry and single-cell RNA sequencing

2023-04-21 | GSE229855 | GEO

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma.

Project description: Not available

| S-EPMC10177077 | biostudies-literature

Impact of Verteporfin on HCC cells

Project description:Together with TEAD4 the Hippo pathway effector YAP stimulates chromosomal instability. Verteporfin is known to disrupt the physical YAP/TEAD interaction and tehrefore might prevent from chromosomal instability in liver cancer. Immortalized HCC cell line hepG2 is treated with Verteporfin for 24 hours.

2016-02-11 | E-GEOD-73396 | biostudies-arrayexpress

Tumor selective proteotoxicity of verteporfin inhibits colon cancer progression independent of YAP1

Project description:Verteporfin (VP) inhibts colon cancer growth in vivo and in cell lines by inducing high molecular weight oligomerization of proteins. The antitumor effect of VP is independent of its YAP inhibitor activity. Tumor hypoxia contributes partly to antitumor effect of VP by impairing clearance of VP-induced high molecular weight aggregates.

2015-10-14 | PXD002793 | Pride

Anti-cancer activity of Cotyledon orbiculata extract

Project description:Anti-cancer activity of Cotyledon orbiculata extract

| PRJNA657067 | ENA

Gene expression profile in gastric cancer cells by Verteporfin (VP)

Project description:Verteporfin (trade name Visudyne) is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 689 nm[1] in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels. Recently, it was reported that VP has chemotherapeutic effect in cancer. To identify the gene expression profile in gastric cancer cells by VP, we performed microarray.

2017-12-26 | GSE77982 | GEO

Impact of Verteporfin on HCC cells

2016-02-11 | GSE73396 | GEO

Selpercatinib mitigates cancer cachexia independent of anti-tumor activity

Project description:Selpercatinib mitigates cancer cachexia independent of anti-tumor activity

| PRJNA1130906 | ENA

Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma

Project description:Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma

| PRJNA1418659 | ENA

Immune modulation underpins the anti-cancer activity of HDAC inhibitors

Project description:Immune modulation underpins the anti-cancer activity of HDAC inhibitors

| PRJNA664188 | ENA